METCB vs. ALT
Compare and contrast key facts about Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: METCB or ALT.
Key characteristics
| METCB | ALT | |
|---|---|---|
| YTD Return | -14.20% | -31.73% |
| 1Y Return | -18.24% | 213.47% |
| Sharpe Ratio | -0.09 | 1.70 |
| Sortino Ratio | 0.23 | 2.61 |
| Omega Ratio | 1.03 | 1.31 |
| Calmar Ratio | -0.12 | 1.85 |
| Martin Ratio | -0.17 | 4.55 |
| Ulcer Index | 26.75% | 40.52% |
| Daily Std Dev | 49.61% | 108.29% |
| Max Drawdown | -37.69% | -99.94% |
| Current Drawdown | -29.85% | -99.72% |
Fundamentals
| METCB | ALT | |
|---|---|---|
| Market Cap | $629.75M | $545.83M |
| EPS | $0.64 | -$1.63 |
| Total Revenue (TTM) | $698.13M | $47.00K |
| Gross Profit (TTM) | $161.51M | -$2.01M |
| EBITDA (TTM) | $120.35M | -$72.69M |
Correlation
The correlation between METCB and ALT is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
METCB vs. ALT - Performance Comparison
In the year-to-date period, METCB achieves a -14.20% return, which is significantly higher than ALT's -31.73% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
METCB vs. ALT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
METCB vs. ALT - Dividend Comparison
METCB's dividend yield for the trailing twelve months is around 8.88%, while ALT has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
METCB Ramaco Resources Inc. | 8.88% | 3.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ALT Altimmune, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.87% |
Drawdowns
METCB vs. ALT - Drawdown Comparison
The maximum METCB drawdown since its inception was -37.69%, smaller than the maximum ALT drawdown of -99.94%. Use the drawdown chart below to compare losses from any high point for METCB and ALT. For additional features, visit the drawdowns tool.
Volatility
METCB vs. ALT - Volatility Comparison
The current volatility for Ramaco Resources Inc. (METCB) is 9.80%, while Altimmune, Inc. (ALT) has a volatility of 16.26%. This indicates that METCB experiences smaller price fluctuations and is considered to be less risky than ALT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
METCB vs. ALT - Financials Comparison
This section allows you to compare key financial metrics between Ramaco Resources Inc. and Altimmune, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities